Common Stock, Shares Authorized of CASI Pharmaceuticals, Inc. from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
CASI Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2021 to 31 Dec 2024.
  • CASI Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending 31 Dec 2024 was 500,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

CASI Pharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 500,000,000 0 0% 31 Dec 2024 20-F 31 Mar 2025 2024 FY
Q4 2023 500,000,000 0 0% 31 Dec 2023 20-F 31 Mar 2025 2024 FY
Q1 2023 500,000,000 31 Mar 2023 20-F 31 Mar 2025 2024 FY
Q4 2022 500,000,000 +250,000,000 +100% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q2 2022 250,000,000 01 Jun 2022 20-F 31 Mar 2025 2024 FY
Q4 2021 250,000,000 31 Dec 2021 20-F 31 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.